Figure S2 from Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses

• DOI: 10.1158/1078-0432.26711134.v1
• Publication Date: 2024-08-15T07:30:38Z
• Authors: Casper W.F. van E...; Hassana el Haddaoui; Songul Kucukcelebi; Disha Vadgama; Amine Fellah; Dana A.M. Mustafa; Joachim G.J.V. Aerts; Casper H.J. van E...; Marcella Willemsen
• Keywords: Cell mediated immunity

<p>Supplementary Figure S2. Relative abundance of peripheral immune cells. (A-D) Boxplots illustrating the differences in cell scores between baseline and post-rintatolimod (A), progressive disease stable patients at (B), (C), delta change (D). The x-axis displays different subsets, y-axis score or (upper right).</p>